<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32143681</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-6606</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>06</Day></PubDate></JournalIssue><Title>Molecular brain</Title><ISOAbbreviation>Mol Brain</ISOAbbreviation></Journal><ArticleTitle>A rare CACNA1H variant associated with amyotrophic lateral sclerosis causes complete loss of Ca<sub>v</sub>3.2&#x2009;T-type channel activity.</ArticleTitle><Pagination><StartPage>33</StartPage><MedlinePgn>33</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">33</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13041-020-00577-6</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by the progressive loss of cortical, brain stem and spinal motor neurons that leads to muscle weakness and death. A previous study implicated CACNA1H encoding for Ca<sub>v</sub>3.2 calcium channels as a susceptibility gene in ALS. In the present study, two heterozygous CACNA1H variants were identified by whole genome sequencing in a small cohort of ALS patients. These variants were functionally characterized using patch clamp electrophysiology, biochemistry assays, and molecular modeling. A previously unreported c.454GTAC&#x2009;&gt;&#x2009;G variant produced an inframe deletion of a highly conserved isoleucine residue in Ca<sub>v</sub>3.2 (p.&#x394;I153) and caused a complete loss-of-function of the channel, with an additional dominant-negative effect on the wild-type channel when expressed in trans. In contrast, the c.3629C&#x2009;&gt;&#x2009;T variant caused a missense substitution of a proline with a leucine (p.P1210L) and produced a comparatively mild alteration of Ca<sub>v</sub>3.2 channel activity. The newly identified &#x394;I153 variant is the first to be reported to cause a complete loss of Ca<sub>v</sub>3.2 channel function. These findings add to the notion that loss-of-function of Ca<sub>v</sub>3.2 channels associated with rare CACNA1H variants may be risk factors in the complex etiology of ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stringer</LastName><ForeName>Robin N</ForeName><Initials>RN</Initials><AffiliationInfo><Affiliation>Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam 2, 16610, Prague, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Third Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jurkovicova-Tarabova</LastName><ForeName>Bohumila</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center of Biosciences, Institute of Molecular Physiology and Genetics, Academy of Sciences, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Sun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haji-Ghassemi</LastName><ForeName>Omid</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Idoux</LastName><ForeName>Romane</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam 2, 16610, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liashenko</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam 2, 16610, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souza</LastName><ForeName>Ivana A</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rzhepetskyy</LastName><ForeName>Yuriy</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam 2, 16610, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacinova</LastName><ForeName>Lubica</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center of Biosciences, Institute of Molecular Physiology and Genetics, Academy of Sciences, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Petegem</LastName><ForeName>Filip</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamponi</LastName><ForeName>Gerald W</ForeName><Initials>GW</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pamphlett</LastName><ForeName>Roger</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Discipline of Pathology, Brain and Mind Centre, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiss</LastName><ForeName>Norbert</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam 2, 16610, Prague, Czech Republic. weiss@uochb.cas.cz.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Brain</MedlineTA><NlmUniqueID>101468876</NlmUniqueID><ISSNLinking>1756-6606</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C479952">CACNA1H protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020747">Calcium Channels, T-Type</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020747" MajorTopicYN="N">Calcium Channels, T-Type</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005799" MajorTopicYN="N">Genes, Dominant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="Y">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040681" MajorTopicYN="N">Structural Homology, Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073336" MajorTopicYN="N">Whole Genome Sequencing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Biophysics</Keyword><Keyword MajorTopicYN="N">CACNA1H</Keyword><Keyword MajorTopicYN="N">Calcium channel</Keyword><Keyword MajorTopicYN="N">Cav3.2 channel</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">Mutation</Keyword><Keyword MajorTopicYN="N">T-type channel</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32143681</ArticleId><ArticleId IdType="pmc">PMC7060640</ArticleId><ArticleId IdType="doi">10.1186/s13041-020-00577-6</ArticleId><ArticleId IdType="pii">10.1186/s13041-020-00577-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marin B, Fontana A, Arcuti S, Copetti M, Boum&#xe9;diene F, Couratier P, et al. Age-specific ALS incidence: a dose-response meta-analysis. Eur J Epidemiol. 2018;33(7):621&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pubmed">29687175</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Boum&#xe9;diene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46(1):57&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5407171</ArticleId><ArticleId IdType="pubmed">27185810</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbot K. Familial versus sporadic amyotrophic lateral sclerosis--a false dichotomy. Brain. 2011;134(Pt 12):3429&#x2013;3431.</Citation><ArticleIdList><ArticleId IdType="pubmed">22051609</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Broeckhoven C, van der Zee J. ALS genes in the genomic era and their implications for FTD. Trends Genet. 2018;34(6):404&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson SB, Downie JM, Tsetsou S, Feusier JE, Figueroa KP, Bromberg MB, et al. The evolving genetic risk for sporadic ALS. Neurology. 2017;89(3):226&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5513819</ArticleId><ArticleId IdType="pubmed">28642336</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero W, Shatunov A, Stahl D, Shoai M, van Rheenen W, Jones AR, et al. ATXN2 trinucleotide repeat length correlates with risk of ALS. Neurobiol Aging. 2017;51:178.e1&#x2013;178.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5302215</ArticleId><ArticleId IdType="pubmed">28017481</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Veldink JH, Saris CG, Blauw HM, van Vught PW, Birve A, et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet. 2009;41(10):1083&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pubmed">19734901</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, et al. ANG mutations segregate with familial and &#x2018;sporadic&#x2019; amyotrophic lateral sclerosis. Nat Genet. 2006;38(4):411&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pubmed">16501576</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Camu W, Halimi JM, Vourc&#x2019;h P, Antar C, Vedrine S, et al. SMN1 gene, but not SMN2, is a risk factor for sporadic ALS. Neurology. 2006;67(7):1147&#x2013;1150.</Citation><ArticleIdList><ArticleId IdType="pubmed">16931506</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinberg KM, Yu B, Koboldt DC, Mardis ER, Pamphlett R. Exome sequencing of case-unaffected-parents trios reveals recessive and de novo genetic variants in sporadic ALS. Sci Rep. 2015;5:9124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4360641</ArticleId><ArticleId IdType="pubmed">25773295</ArticleId></ArticleIdList></Reference><Reference><Citation>Rzhepetskyy Y, Lazniewska J, Blesneac I, Pamphlett R, Weiss N. CACNA1H missense mutations associated with amyotrophic lateral sclerosis alter Cav3.2 T-type calcium channel activity and reticular thalamic neuron firing. Channels (Austin) 2016;10(6):466&#x2013;477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5034776</ArticleId><ArticleId IdType="pubmed">27331657</ArticleId></ArticleIdList></Reference><Reference><Citation>Meltz Steinberg K, Nicholas TJ, Koboldt DC, Yu B, Mardis E, Pamphlett R. Whole genome analyses reveal no pathogenetic single nucleotide or structural differences between monozygotic twins discordant for amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5&#x2013;6):385&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pubmed">25960086</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitrini R. Frontotemporal dementia and amyotrophic lateral sclerosis: revisiting one of the first case reports with neuropathology examination. Dement Neuropsychol. 2014;8(1):83&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5619453</ArticleId><ArticleId IdType="pubmed">29213884</ArticleId></ArticleIdList></Reference><Reference><Citation>Rzhepetskyy Y, Lazniewska J, Proft J, Campiglio M, Flucher BE, Weiss N. A Cav3.2/Stac1 molecular complex controls T-type channel expression at the plasma membrane. Channels (Austin) 2016;10(5):346&#x2013;354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4988463</ArticleId><ArticleId IdType="pubmed">27149520</ArticleId></ArticleIdList></Reference><Reference><Citation>Proft J, Rzhepetskyy Y, Lazniewska J, Zhang FX, Cain SM, Snutch TP, et al. The Cacna1h mutation in the GAERS model of absence epilepsy enhances T-type Ca2+ currents by altering calnexin-dependent trafficking of Cav3.2 channels. Sci Rep. 2017;7(1):11513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5599688</ArticleId><ArticleId IdType="pubmed">28912545</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourinet E, Alloui A, Monteil A, Barr&#xe8;re C, Couette B, Poirot O, et al. Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J. 2005;24(2):315&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC545807</ArticleId><ArticleId IdType="pubmed">15616581</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell KL, Cain SM, Ng C, Sirdesai S, David LS, Kyi M, et al. A Cav3.2 T-type calcium channel point mutation has splice-variant-specific effects on function and segregates with seizure expression in a polygenic rat model of absence epilepsy. J Neurosci. 2009;29(2):371&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6664949</ArticleId><ArticleId IdType="pubmed">19144837</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza IA, Gandini MA, Wan MM, Zamponi GW. Two heterozygous Cav3.2 channel mutations in a pediatric chronic pain patient: recording condition-dependent biophysical effects. Pflugers Arch. 2016;468(4):635&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pubmed">26706850</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson D, Mehaffey WH, Iftinca M, Rehak R, Engbers JD, Hameed S, et al. Regulation of neuronal activity by Cav3-Kv4 channel signaling complexes. Nat Neurosci. 2010;13(3):333&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pubmed">20154682</ArticleId></ArticleIdList></Reference><Reference><Citation>Engbers JD, Anderson D, Asmara H, Rehak R, Mehaffey WH, Hameed S, et al. Intermediate conductance calcium-activated potassium channels modulate summation of parallel fiber input in cerebellar Purkinje cells. Proc Natl Acad Sci U S A. 2012;109(7):2601&#x2013;2606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3289366</ArticleId><ArticleId IdType="pubmed">22308379</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehak R, Bartoletti TM, Engbers JD, Berecki G, Turner RW, Zamponi GW. Low voltage activation of KCa1.1 current by Cav3-KCa1.1 complexes. PLoS One. 2013;8(4):e61844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3633930</ArticleId><ArticleId IdType="pubmed">23626738</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Caballero A, Gandini MA, Huang S, Chen L, Souza IA, Dang YL, et al. Cav3.2 calcium channel interactions with the epithelial sodium channel ENaC. Mol Brain. 2019;12(1):12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6368719</ArticleId><ArticleId IdType="pubmed">30736831</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Huang G, Wu Q, Wu K, Li R, Lei J, et al. Cryo-EM structures of apo and antagonist-bound human Cav3.1. Nature. 2019;576(7787):492&#x2013;497.</Citation><ArticleIdList><ArticleId IdType="pubmed">31766050</ArticleId></ArticleIdList></Reference><Reference><Citation>Talley EM, Cribbs LL, Lee JH, Daud A, Perez-Reyes E, Bayliss DA. Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J Neurosci. 1999;19(6):1895&#x2013;1911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782581</ArticleId><ArticleId IdType="pubmed">10066243</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Bochorishvili G, Chen Y, Salvati KA, Zhang P, Dubel SJ, et al. CaV3.2 calcium channels control NMDA receptor-mediated transmission: a new mechanism for absence epilepsy. Genes Dev. 2015;29(14):1535&#x2013;1551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4526737</ArticleId><ArticleId IdType="pubmed">26220996</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis. 2004;15(3):601&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JL, Lomen-Hoerth C, Murphy J, Henry RG, Kramer JH, Miller BL, et al. A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology. 2005;65(1):75&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">16009889</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma KR, Saigal G, Maudsley AA, Govind V. 1H MRS of basal ganglia and thalamus in amyotrophic lateral sclerosis. NMR Biomed. 2011;24(10):1270&#x2013;1276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3210902</ArticleId><ArticleId IdType="pubmed">21404355</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma KR, Sheriff S, Maudsley A, Govind V. Diffusion tensor imaging of basal ganglia and thalamus in amyotrophic lateral sclerosis. J Neuroimaging. 2013;23(3):368&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4896398</ArticleId><ArticleId IdType="pubmed">22273090</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Elamin M, Byrne S, McLaughlin RL, Kenna K, Vajda A, et al. Basal ganglia involvement in amyotrophic lateral sclerosis. Neurology. 2013;81(24):2107&#x2013;2115.</Citation><ArticleIdList><ArticleId IdType="pubmed">24212388</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke RA, K&#xf6;rner S, Filippini N, Douaud G, Knight S, Talbot K, et al. Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain. 2014;137(Pt 9):2546&#x2013;2555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4132644</ArticleId><ArticleId IdType="pubmed">24951638</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu S, Menke RAL, Talbot K, Kiernan MC, Turner MR. Regional thalamic MRI as a marker of widespread cortical pathology and progressive frontotemporal involvement in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2018;89(12):1250&#x2013;1258.</Citation><ArticleIdList><ArticleId IdType="pubmed">30049750</ArticleId></ArticleIdList></Reference><Reference><Citation>Canto-Bustos M, Loeza-Alcocer E, Gonz&#xe1;lez-Ram&#xed;rez R, Gandini MA, Delgado-Lezama R, Felix R. Functional expression of T-type Ca2+ channels in spinal motoneurons of the adult turtle. PLoS One. 2014;9:e108187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4177857</ArticleId><ArticleId IdType="pubmed">25255145</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, David G. Stimulation-induced Ca (2+) influx at nodes of Ranvier in mouse peripheral motor axons. J Physiol. 2016;594(1):39&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4704498</ArticleId><ArticleId IdType="pubmed">26365250</ArticleId></ArticleIdList></Reference><Reference><Citation>Shtonda B, Avery L. CCA-1, EGL-19 and EXP-2 currents shape action potentials in the Caenorhabditis elegans pharynx. J Exp Biol. 2005;208(Pt 11):2177&#x2013;2190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1351090</ArticleId><ArticleId IdType="pubmed">15914661</ArticleId></ArticleIdList></Reference><Reference><Citation>Steger KA, Shtonda BB, Thacker C, Snutch TP, Avery L. The C. elegans T-type calcium channel CCA-1 boosts neuromuscular transmission. J Exp Biol. 2005;208(Pt 11):2191&#x2013;2203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1382270</ArticleId><ArticleId IdType="pubmed">15914662</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicoletti M, Loppini A, Chiodo L, Folli V, Ruocco G, Filippi S. Biophysical modeling of C. elegans neurons: Single ion currents and whole-cell dynamics of AWCon and RMD. PLoS One. 2019;14(7):e0218738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6602206</ArticleId><ArticleId IdType="pubmed">31260485</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JW, Oh HA, Lee SH, Kim KC, Eun PH, Ko MJ, et al. T-type calcium channels are required to maintain viability of neural progenitor cells. Biomol Ther (Seoul) 2018;26(5):439&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6131011</ArticleId><ArticleId IdType="pubmed">29463073</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss N, Zamponi GW. Genetic T-type calcium channelopathies. J Med Genet. 2020;57(1):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6929700</ArticleId><ArticleId IdType="pubmed">31217264</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss N, Zamponi GW. T-type calcium channels: from molecule to therapeutic opportunities. Int J Biochem Cell Biol. 2019;108:34&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">30648620</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubel SJ, Altier C, Chaumont S, Lory P, Bourinet E, Nargeot J. Plasma membrane expression of T-type calcium channel alpha (1) subunits is modulated by high voltage-activated auxiliary subunits. J Biol Chem. 2004;279(28):29263&#x2013;29269.</Citation><ArticleIdList><ArticleId IdType="pubmed">15123697</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter MT, McMillan HJ, Tomin A, Weiss N. Compound heterozygous CACNA1H mutations associated with severe congenital amyotrophy. Channels (Austin) 2019;13(1):153&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6527065</ArticleId><ArticleId IdType="pubmed">31070086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ondacova K, Karmazinova M, Lazniewska J, Weiss N, Lacinova L. Modulation of Cav3.2 T-type calcium channel permeability by asparagine-linked glycosylation. Channels (Austin) 2016;10(3):175&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4954584</ArticleId><ArticleId IdType="pubmed">26745591</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurkovicova-Tarabova B, Cmarko L, Rehak R, Zamponi GW, Lacinova L, Weiss N. Identification of a molecular gating determinant within the carboxy terminal region of Cav3.3&#x2009;T-type channels. Mol Brain. 2019;12(1):34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6454634</ArticleId><ArticleId IdType="pubmed">30961646</ArticleId></ArticleIdList></Reference><Reference><Citation>Altier C, Khosravani H, Evans RM, Hameed S, Peloquin JB, Vartian BA, et al. ORL1 receptor-mediated internalization of N-type calcium channels. Nat Neurosci. 2006;9(1):31&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">16311589</ArticleId></ArticleIdList></Reference><Reference><Citation>Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46(W1):W296&#x2013;W303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6030848</ArticleId><ArticleId IdType="pubmed">29788355</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>